Indian Immunologicals to make drug material for 10 mn Covaxin doses a month

IIL has repurposed its manufacturing unit in Hyderabad, procured key raw materials and consumables apart from equipment at 'breakneck' speed; production commenced in July

Indian Immunologicals (IIL) will make drug substances or raw material to make 3-4 million doses of Covid-19 vaccine Covaxin a month now, which will be scale up to 10 million doses a month by December.

IIL and Bharat Biotech International (BBIL), which joined hands in April, have signed four agreements. IIL has repurposed its manufacturing facility in Hyderabad, procured key raw materials and consumables apart from equipment. IIL claimed that these were done at 'breakneck' speed and production commenced in July.

The batches produced at IIL’s manufacturing facility have been tested at BBIL. The yields are more than expected, the